Milliet

LALCA Attendees: Don’t miss the Caris Life Sciences Symposium “Upfront Broad Profiling Improves Outcomes in NSCLC,” featuring speakers Luis Raez, Edgardo S. Santos, and George Oblitas.

¿Sabía que hay una mejor manera para que usted o su ser querido luchen contra el cáncer?

Nuestro perfil molecular evalúa cada gen en el ADN, el ARN y las proteínas para revelar un modelo molecular único. Esto ayuda a los oncólogos a identificar qué opciones de tratamiento son más efectivas.

Obtenga más información sobre nuestras pruebas: http://ow.ly/yH3q50JVZoS

Did you know there's a better way for you or your loved one to fight cancer?

Our molecular profiling assesses every gene in DNA, RNA, and proteins to reveal a unique molecular blueprint. This helps oncologists identify which treatment options are more effective.

Learn more about our testing: http://ow.ly/yH3q50JVZoS

Right-In-Time Network ofrece a pacientes y médicos opciones de tratamiento alternativas y acceso a los últimos medicamentos contra el cáncer en desarrollo.

¿Quieres conocer este programa y unirte a la red?
Regístrate aquí: http://ow.ly/xjsb50JACku

The Right-In-Time Network offers patients and physicians alternative treatment options and access to the latest cancer drugs in development.

Want to learn about this program and join the network?
Sign up here: http://ow.ly/xjsb50JACku

When you or your loved one are diagnosed with cancer, you deserve the best information available. Correctly identifying the cause of your cancer is critical. Caris will analyze your cancer with the most comprehensive test on the market, examining every possible gene to provide the most precise information available.

Ask your doctor about Caris molecular profiling: http://ow.ly/HEQE50IUwoe

Discover comprehensive molecular profiling and how it provides a blueprint to help you and your doctor develop a personalized cancer treatment plan. Learn more: http://ow.ly/FCX850IbOYR

Caris conducts comprehensive, detailed data analysis on samples to help oncologists identify the unique molecular makeup of a patient’s tumor. Together, we are treating cancer smarter. Learn more: http://ow.ly/HYl350IbLS2

Every cancer is unique, and every person’s cancer is unique. As the pioneer in comprehensive profiling, Caris provides transformative insights to help physicians identify personalized treatment options. Get more information on Caris testing:
http://ow.ly/MEGe50IbOsH

Looking for an oncologist with expertise? Use our comprehensive database to find a physician: https://www.carislifesciences.com/your-treatment/ -a-doc

Tampa General Hospital Cancer Institute (TGH Cancer Institute) joins Caris’ Precision Oncology Alliance (POA) – an extensive network of cancer institutions committed to utilizing clinical data to advance patient care and outcomes.

“TGH Cancer Institute’s focus on innovation and research builds upon the POA’s goal to promote broad-based collaboration among our member institutions in precision oncology research to improve outcomes of all patients with cancer,” said Chadi Nabhan, M.D., MBA, FACP, Chairman of the Caris Precision Oncology Alliance.

Learn more: http://ow.ly/wwWL50I6ok7

Caris partners with physicians to help cancer patients receive the most accurate diagnosis and the best possible therapy. Learn more about the invaluable information Caris provides to doctors: http://ow.ly/6ubB50HT588

Caris is revolutionizing precision medicine to provide physicians and patients with the highest quality information about cancer treatment options. Learn more: http://ow.ly/Z7lf50HT78Q

New discoveries are increasing cancer treatment options at an unprecedented rate. Discover the range of testing Caris profiling provides, ensuring innovative treatments are at the forefront of patient care.

Learn how to get profiled: http://ow.ly/tjhH50HJCeo

We are pioneers in molecular science with a long history of driving change and innovation in precision medicine.

Read how Caris is changing the lives of cancer patients: http://ow.ly/GSJV50HJC4Y

La Organización Mundial de la Salud, el Centro Internacional de Investigaciones sobre el Cáncer (CIIC) y la Unión Internacional Contra el Cáncer (UICC) celebran el 4 de febrero de cada año como el Día Mundial contra el Cáncer,un día Internacional con el objetivo de aumentar la concientización y movilizar a la sociedad para avanzar en la prevención y control de esta enfermedad.

www.millietmedicine.com
www.carislifesciences.com